Molecular profile of bladder cancer progression to clinically aggressive subtypes

CC Guo, S Lee, JG Lee, H Chen, M Zaleski… - Nature Reviews …, 2024 - nature.com
Bladder cancer is a histologically and clinically heterogenous disease. Most bladder
cancers are urothelial carcinomas, which frequently develop distinct histological subtypes …

The urothelial gene regulatory network: understanding biology to improve bladder cancer management

M Ramal, S Corral, M Kalisz, E Lapi, FX Real - Oncogene, 2024 - nature.com
The urothelium is a stratified epithelium composed of basal cells, one or more layers of
intermediate cells, and an upper layer of differentiated umbrella cells. Most bladder cancers …

FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression

A Okato, T Utsumi, M Ranieri, X Zheng… - The Journal of …, 2024 - Am Soc Clin Investig
The combination of targeted therapy with immune checkpoint inhibition (ICI) is an area of
intense interest. We studied the interaction of fibroblast growth factor receptor (FGFR) …

MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation

J Ma, L Li, B Ma, T Liu, Z Wang, Q Ye, Y Peng… - Nature …, 2024 - nature.com
Abstract CDK4/6 inhibitors (CDK4/6i) show anticancer activity in certain human
malignancies, such as breast cancer. However, their application to other tumor types and …

p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response

F Serra, A Nieto-Aliseda, L Fanlo-Escudero… - Nature …, 2024 - nature.com
Activation of the p53 tumor suppressor triggers a transcriptional program to control cellular
response to stress. However, the molecular mechanisms by which p53 controls gene …

Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes

A Khoo, M Govindarajan, Z Qiu, LY Liu… - Nature …, 2024 - nature.com
Urine is a complex biofluid that reflects both overall physiologic state and the state of the
genitourinary tissues through which it passes. It contains both secreted proteins and proteins …

The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer

M Di Nardo, S Astigiano, S Baldari, MM Pallotta… - Journal of Experimental …, 2024 - Springer
Background SMC1A is a subunit of the cohesin complex that participates in many DNA-and
chromosome-related biological processes. Previous studies have established that SMC1A is …

Non-small cell lung carcinoma with clear cell features and FGFR3:: TACC3 gene rearrangement: clinicopathologic and next generation sequencing study of 7 cases

D Suster, AC Mackinnon, N Ronen… - The American Journal …, 2024 - journals.lww.com
Seven cases of primary lung tumors characterized histologically by clear cell morphology
and a distinctive FGFR3:: TACC3 gene rearrangement are described. The tumors arose in 4 …

Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation

BJ Viergever, DAE Raats, V Geurts… - British journal of …, 2024 - nature.com
Background Bladder cancer is one of the most common cancer types worldwide. Generally,
research relies on invasive sampling strategies. Methods Here, we generate bladder cancer …

The sex gap in bladder cancer survival—a missing link in bladder cancer care?

P Toren, A Wilkins, K Patel, A Burley, T Gris… - Nature Reviews …, 2024 - nature.com
The differences in bladder cancer outcomes between the sexes has again been highlighted.
Uncommon among cancers, bladder cancer outcomes are notably worse for women than for …